Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)
Lin Zhang, Wei Mao, Dan Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

Diagnosis and Management of Acute Pancreatitis
Guru Trikudanathan, Cemal Yazıcı, Anna Evans Phillips, et al.
Gastroenterology (2024) Vol. 167, Iss. 4, pp. 673-688
Closed Access | Times Cited: 24
Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database
Khalidah A. Alenzi, Deemah S. Alsuhaibani, Bader Batarfi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting system
Qiubai Jin, Jiufei Fang, Feihong Ren, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Pancreatitis associated with BRAF inhibitors: a disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting System
Shoujun Wang, Jinjing Wang, Huahua Zhang, et al.
International Journal of Clinical Pharmacy (2025)
Closed Access
Risk factors for drug-related urticaria: an analysis of the FDA adverse event reporting system (FAERS)
Wenshan Yang, Guoyou Zu, Pan Tian, et al.
Allergy medicine. (2025), pp. 100046-100046
Open Access
Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
Zhiyong Dong, M. He, Y. Hu
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases
Tao Wang, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Enhancing Intrapancreatic Fat Deposition and Pancreatitis Research With Additional Considerations
Qing Zhou
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 1
Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium comparing the FDA Adverse Event Reporting System, 2017–2023
Eugene A. Kiyatkin
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Treatment approaches in autoimmune pancreatitis (Review)
Vlad Pădureanu, Alice Nicoleta Drăgoescu, Rodica Pădureanu, et al.
Biomedical Reports (2023) Vol. 20, Iss. 2
Open Access | Times Cited: 3
Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
Yanjun Lu, Qian Xu, Sixi Zhu
Frontiers in Pharmacology (2024) Vol. 15
Open Access
“Every rose has its thorn” – A case report on Olanzapine-induced pancreatitis
Sharanya Mohan, George Zacharia, Shawn Serrao, et al.
Annals of Indian Psychiatry (2024)
Open Access
Page 1

Scroll to top